Compugen (CGEN) Retained Earnings (2009 - 2025)
Compugen (CGEN) posted quarterly Retained Earnings of -$453.4 million for Q4 2025, up 7.23% year-over-year from -$422.8 million in Q4 2024, and up 9.91% on a QoQ basis from -$503.3 million in Q2 2025.
Compugen (CGEN) Retained Earnings (2009 - 2025) Analysis & Trends
Compugen has reported Retained Earnings for 17 years, with the latest figure at -$453.4 million in Q4 2025.
- Retained Earnings for Q4 2025 came in at -$453.4 million, up 7.23% year-over-year; the trailing twelve-month figure through Dec 2025 was -$453.4 million (up 7.23% YoY), and the FY2025 annual result was -$453.4 million, up 7.23% from the prior year.
- Retained Earnings rose to -$453.4 million in Q4 2025, from -$503.3 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$407.3 million in Q2 2021 and troughed at -$503.3 million in Q2 2025.
- A 5-year average of -$460.4 million and a median of -$465.1 million in 2022 frame the typical range for Retained Earnings.
- The widest annual swing landed in 2021, when Retained Earnings decreased 9.62%; it then increased 7.23% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$422.1 million in 2021, then decreased by 7.98% to -$455.8 million in 2022, then slipped by 4.11% to -$474.5 million in 2023, then slipped by 3.0% to -$488.8 million in 2024, then climbed by 7.23% to -$453.4 million in 2025.
- Per Business Quant data, the three most recent Retained Earnings figures were -$453.4 million in Q4 2025, -$503.3 million in Q2 2025, and -$488.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -453.42 Mn |
| Jun 30, 2025 | -503.28 Mn |
| Dec 31, 2024 | -488.76 Mn |
| Jun 30, 2024 | -483.92 Mn |
| Dec 31, 2023 | -474.53 Mn |
| Jun 30, 2023 | -474.39 Mn |
| Dec 31, 2022 | -455.77 Mn |
| Jun 30, 2022 | -440.93 Mn |
| Dec 31, 2021 | -422.08 Mn |
| Jun 30, 2021 | -407.28 Mn |
| Dec 31, 2020 | -387.88 Mn |
| Jun 30, 2020 | -371.55 Mn |
| Dec 31, 2019 | -358.18 Mn |
| Jun 30, 2019 | -345.23 Mn |
| Dec 31, 2018 | -330.84 Mn |
| Jun 30, 2018 | -318.33 Mn |
| Dec 31, 2017 | -308.24 Mn |
| Jun 30, 2017 | -289.06 Mn |
| Dec 31, 2016 | -270.97 Mn |
| Jun 30, 2016 | -254.69 Mn |